Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses

Ovarian cancer biomarkers for molecular biosensors and translational medicine

(2010) K Stephen Suh et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy

(2010) Caroline M. Woolston et al.   FREE RADICAL BIOLOGY AND MEDICINE

Predictive Value of Symptoms for Early Detection of Ovarian Cancer

(2010) M. A. Rossing et al.   JNCI-Journal of the National Cancer Institute

Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma

(2009) Mee-Kyung Cha et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IgE myeloma with elevated level of serum CA125

(2009) Man-ling Wang et al.   Journal of Zhejiang University-SCIENCE B

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?

(2008) Vladimir Nossov et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax

(2007) P. Bagan et al.   EUROPEAN RESPIRATORY JOURNAL